Florent BARBAULT

City:

Paris

Country:

France

Published Applications:

Last publication date:

2024-10-24

Top Assignees for applications by Florent BARBAULT

The entities that hold a legal rights for patent applications filed by inventor BARBAULT Florent:

IMAGINE 3 Paris, France
Centre National de la Recherche Scientifique (CNRS 3 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 3 Paris, France
UNIVERSITÉ PARIS CITÉ 2 Paris, France
Assistance Publique-Hopitaux De Paris 2 Paris, France
Assitance Publique-Hopitaux de Paris 1 Paris, France
UNIVERSITE PARIS DESCARTES 1 Paris, France
Universite Paris Diderot-Paris 7 1 Paris, France

Recent patent applications by BARBAULT Florent

Florent BARBAULT from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-24

US20240350490A1

Human necessities

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

#2 | 2023-03-09

US20230075776A1

Human necessities

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

#3 | 2022-02-03

US20220031696A9

Human necessities

Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3

#4 | 2020-08-06

US20200246337A1

Human necessities

Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3

#5 | 2018-06-14

US20180161327A1

Human necessities

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

#6 | 2016-02-25

US20160051549A1

Human necessities

Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3

InventorID:

1449879 ⎘